Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.20.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Preferred Stock
Cumulative Effect Period of Adoption Adjusted Balance
Preferred Stock
Common Stock
Cumulative Effect Period of Adoption Adjusted Balance
Common Stock
Additional Paid-in- Capital
Cumulative Effect Period of Adoption Adjusted Balance
Additional Paid-in- Capital
Treasury Stock
Cumulative Effect Period of Adoption Adjusted Balance
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect Period of Adoption Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Cumulative Effect Period of Adoption Adjustment
Accumulated Deficit
Cumulative Effect Period of Adoption Adjusted Balance
Accumulated Deficit
Cumulative Effect Period of Adoption Adjustment
Cumulative Effect Period of Adoption Adjusted Balance
Total
Increase (Decrease) in Stockholders' Equity                                
Effect of new accounting adoption $ 3 $ 3 $ 38 $ 38 $ 183,139 $ 183,139 $ (7,146) $ (7,146) $ 579 $ 579 $ 1,623 $ (136,168) $ (137,791) $ 1,623 $ 40,445 $ 38,822
Beginning balance (in shares) at Dec. 29, 2018 2,771 2,771 34,992 34,992                        
Beginning balance at Dec. 29, 2018 $ 3 $ 3 $ 38 $ 38 183,139 183,139 (7,146) (7,146) 579 579 1,623 (136,168) (137,791) 1,623 40,445 38,822
Increase (Decrease) in Stockholders' Equity                                
Effect of new accounting adoption $ 3 $ 3 $ 38 $ 38 $ 183,139 187,147 $ (7,146) (7,146) $ 579 214 $ 1,623 $ (136,168) (167,876) $ 1,623 $ 40,445 12,380
Net loss                         (31,548)     (31,548)
Issuance of shares in connection with stock option exercises           460                   $ 460
Issuance of shares in connection with stock option exercises (in shares)       305                       304
Issuance of shares in connection with restricted stock units vesting           (302)                   $ (302)
Issuance of shares in connection with restricted stock units vesting (in shares)       795                        
Issuance of shares in connection with BOD Fees           19                   19
Issuance of shares in connection with BOD Fees (in shares)       16                        
Share-based compensation           3,710                   3,710
Dividends on preferred stock           121       (313)     (160)     (352)
Dividends on preferred stock (in shares)       59                        
Effect of changes in foreign currencies                   (52)           (52)
Ending balance (in shares) at Dec. 28, 2019   2,771   36,167                        
Ending balance at Dec. 28, 2019   $ 3   $ 38   187,147   (7,146)   214     (167,876)     12,380
Increase (Decrease) in Stockholders' Equity                                
Effect of new accounting adoption   3   38   187,147   (7,146)   214     (167,876)     12,380
Effect of new accounting adoption   3   51   260,260   (7,146)   (215)     (169,461)     83,489
Net loss                         (1,513)     (1,513)
Issuance of common stock, net of underwriters' offering expenses and commissions       $ 5   60,456                   60,461
Issuance of common stock, net of underwriters' offering expenses and commissions (in shares)       4,900                        
Issuance of shares in connection with stock option exercises       $ 3   3,703                   $ 3,706
Issuance of shares in connection with stock option exercises (in shares)       2,200                       2,200
Issuance of shares in connection with restricted stock units vesting       $ 2   457                   $ 459
Issuance of shares in connection with restricted stock units vesting (in shares)       2,000                        
Issuance of shares in connection with BOD Fees           22                   22
Issuance of shares in connection with BOD Fees (in shares)       8                        
Share-based compensation           8,437                   8,437
Dividends on preferred stock           38             (72)     (34)
Dividends on preferred stock (in shares)       45                        
Conversion of preferred stock   $ (3)   $ 3                        
Conversion of preferred stock (in shares)   (2,771)   2,771                        
Actuarial loss on defined benefit plan                   (400)           (400)
Unrealized gain on investments                   57           57
Effect of changes in foreign currencies                   (86)           (86)
Ending balance (in shares) at Jan. 02, 2021       48,091                        
Ending balance at Jan. 02, 2021       $ 51   260,260   (7,146)   (215)     (169,461)     83,489
Increase (Decrease) in Stockholders' Equity                                
Effect of new accounting adoption       $ 51   $ 260,260   $ (7,146)   $ (215)     $ (169,461)     $ 83,489